On August 5, 2024, Hualing Medicine (stock code: 02552.HK) submitted its latest monthly securities movement report to the Hong Kong Securities Clearing Company, reporting on the company's share capital movement as of July 31, 2024. The report shows that Hualing Medicine's legal/registered share capital and issued share quantity remained unchanged during that month, with a total of 2,000,000,000 shares, each with a par value of 0.001 US dollars, and a total legal/registered share capital of 2,000,000 US dollars. At the same time, the number of the company's issued shares (excluding treasury shares) remained at 1,055,588,761 shares. In addition, the company's share option plan did not see any changes during that month, and there was no issuance of new shares or treasury shares. The report also confirms that all securities issuance or transfer of treasury shares for sale or transfer have been authorized by the board of directors and comply with relevant listing rules and regulations.

On August 5, 2024, Hualing Medicine (stock code: 02552.HK) submitted its latest monthly securities movement report to the Hong Kong Securities Clearing Company, reporting on the company's share capital movement as of July 31, 2024. The report shows that Hualing Medicine's legal/registered share capital and issued share quantity remained unchanged during that month, with a total of 2,000,000,000 shares, each with a par value of 0.001 US dollars, and a total legal/registered share capital of 2,000,000 US dollars. At the same time, the number of the company's issued shares (excluding treasury shares) remained at 1,055,588,761 shares. In addition, the company's share option plan did not see any changes during that month, and there was no issuance of new shares or treasury shares. The report also confirms that all securities issuance or transfer of treasury shares for sale or transfer have been authorized by the board of directors and comply with relevant listing rules and regulations.